|
Vonderheid, E C; Zhang, Q; Lessin, S R et al. (1998) Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma. J Am Acad Dermatol 38:207-20
|
|
Wasik, M A; Vonderheid, E C; Bigler, R D et al. (1996) Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications. Arch Dermatol 132:42-7
|
|
Marks, D I; Vonderheid, E C; Kurz, B W et al. (1996) Analysis of p53 and mdm-2 expression in 18 patients with Sezary syndrome. Br J Haematol 92:890-9
|
|
Vonderheid, E C; Bigler, R D; Greenberg, A S et al. (1994) Extracorporeal photopheresis and recombinant interferon alfa 2b in Sezary syndrome. Use of dual marker labeling to monitor therapeutic response. Am J Clin Oncol 17:255-63
|
|
Esfahani, M; Bigler, R D; Alfieri, J L et al. (1993) Lipoproteins upregulate high affinity Fc receptors in human monocytes. Biochem Biophys Res Commun 191:610-6
|
|
Esfahani, M; Bigler, R D; Alfieri, J L et al. (1993) Cholesterol regulates the cell surface expression of glycophospholipid-anchored CD14 antigen on human monocytes. Biochim Biophys Acta 1149:217-23
|
|
Esfahani, M; Bigler, R D; Gressen, E (1993) Effect of lovastatin on cell surface expression of Fc receptors or CD14 antigen in human monocytes. Biochem Pharmacol 46:2333-6
|
|
Hubbell, H R; Vargas, H E; Tsujimoto, K L et al. (1992) Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograft. Cancer Immunol Immunother 35:151-7
|
